Inhibition of Hedgehog signaling ameliorates foam cell formation by promoting autophagy in early atherosclerosis

Cell Death Dis. 2023 Nov 14;14(11):740. doi: 10.1038/s41419-023-06270-5.

Abstract

Macrophages are the origin of most foam cells in the early stage of atherosclerotic plaques. However, the mechanism involved in the formation of macrophage-derived foam cell formation remains unclear. Here, we revealed that the hedgehog (Hh) signaling is critical in autophagy-lysosome pathway regulation and macrophage-derived foam cell formation. Inhibition of Hh signaling by vismodegib ameliorated lipid deposition and oxidative stress level in atherosclerotic plaques in high-fat diet-fed apoE-/- mice. For mechanistic study, how the Hh signaling modulate the process of foam cell formation were accessed afterward. Unexpectedly, we found that suppression of Hh signaling in apoE-/- mice had no significant impact on circulating cholesterol levels, indicating that Hh pathway modulate the procession of atherosclerotic plaque not through a traditional lipid-lowing mechanism. Instead, vismodegib was found to accelerate autophagosomes maturation as well as cholesterol efflux in macrophage-derived foam cell and in turn improve foam cell formation, while autophagy inhibitors (LY294002 or CQ) administration significantly attenuated vismodegib-induced cholesterol efflux and reversed the effect on foam cell formation. Therefore, our result demonstrated that inhibition of the Hh signaling pathway increases cholesterol efflux and ameliorates macrophage-derived foam cell formation by promoting autophagy in vitro. Our data thus suggested a novel therapeutic target of atherosclerosis and indicated the potential of vismodegib to treat atherosclerosis.

MeSH terms

  • Anilides*
  • Animals
  • Apolipoproteins E / genetics
  • Apolipoproteins E / metabolism
  • Atherosclerosis* / drug therapy
  • Atherosclerosis* / metabolism
  • Autophagy
  • Cholesterol / metabolism
  • Foam Cells / metabolism
  • Hedgehog Proteins / metabolism
  • Lipids / pharmacology
  • Mice
  • Plaque, Atherosclerotic* / drug therapy
  • Plaque, Atherosclerotic* / metabolism
  • Pyridines*
  • Signal Transduction

Substances

  • HhAntag691
  • Hedgehog Proteins
  • Cholesterol
  • Lipids
  • Apolipoproteins E
  • Anilides
  • Pyridines